Concepedia

Laura S. Collins

LS

7

Publications

1K

Citations

7

H-Index

1988

Active since

Affiliations

Dana-Farber/Harvard Cancer Center(Current)

Evotec (United Kingdom)

Dana-Farber Cancer Institute

Sepragen Corporation (United States)

Harvard University Press

Laura S. Collins is an author at Dana-Farber/Harvard Cancer Center specializing in medicine, tumor biology, and cancer research.

Top concepts

Publications per year

1988–2008

7

Publications

7

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

Nagma Khan, Michael Jeffers, Sampath Kumar et al. · Biochemical Journal · 2007 · 707 citations · Full text

, , +20

The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo

Anthony Tumber, Laura S. Collins, Kamille Dumong Petersen et al. · Cancer Chemotherapy and Pharmacology · 2006 · 78 citations

, , +6

Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.

Terence S. Herman, Beverly A. Teicher, Victor Chan et al. · PubMed · 1988 · 67 citations

, , +20

Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures.

Terence S. Herman, Beverly A. Teicher, Laura S. Collins · PubMed · 1988 · 67 citations

, , +15

Effect of heat on the cytotoxicity and interaction with DNA of a series of platinum complexes

Terence S. Herman, Beverly A. Teicher, Victor Chan et al. · International Journal of Radiation Oncology*Biology*Physics · 1989 · 46 citations

, , +3

Rows per page

1–5 of 7